Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Reports First-Quarter 2018 Financial Results
- Reports First-Quarter Diluted EPS of $1.74 on a GAAP Basis; Adjusted Diluted EPS of $1.87 Reflects Growth of 46.1 Percent - Delivers First-Quarter Net Revenues of $7.934 Billion; Net Revenues Increased 17.6 Percent on an Operational Basis - First-Quarter Global HUMIRA Sales of $4.709 Billion
Toggle Summary AbbVie to Present at the Deutsche Bank's 43rd Annual Health Care Conference
NORTH CHICAGO, Ill. , April 18, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Deutsche Bank's 43 rd Annual Health Care Conference on Wednesday, May 9, 2018 . Bill Chase , executive vice president and chief financial officer,
Toggle Summary AbbVie to Host First-Quarter 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , April 6, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2018 financial results on Thursday, Apr. 26, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the Barclays Global Healthcare Conference
NORTH CHICAGO, Ill. , Feb. 26, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Barclays Global Healthcare Conference on Thursday, March 15, 2018 . Bill Chase , executive vice president and chief financial officer, will present at 8 a.m. Central time .
Toggle Summary AbbVie to Present at the Cowen and Company 38th Annual Health Care Conference
NORTH CHICAGO, Ill. , Feb. 22, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 . Bill Chase , executive vice president and chief financial officer will present at 7:00 a.m. Central time .
Toggle Summary AbbVie Increases Dividend and Announces New Stock Repurchase Program
NORTH CHICAGO, Ill. , Feb. 15, 2018 /PRNewswire/ -- The board of directors of AbbVie (NYSE: ABBV) increased the company's quarterly cash dividend by 35 percent from $0.71 per share to $0.96 per share and authorized a new $10 billion stock repurchase program.  The cash dividend is payable May 15,
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results
- Reports Full-Year Diluted EPS of $3.30 on a GAAP Basis; Adjusted Diluted EPS of $5.60 Reflects Growth of 16.2 Percent - Delivers Full-Year Net Revenues of $28.216 Billion; Adjusted Net Revenues Increased 10.1 Percent on an Operational Basis - Full-Year Global HUMIRA Sales of $18.427 Billion
Toggle Summary AbbVie to Host Fourth-Quarter 2017 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 12, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its fourth-quarter 2017 financial results on Friday, Jan. 26, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the 36th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 20, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10:30 a.m. Central time .
Toggle Summary AbbVie to Present at the Goldman Sachs 10th Annual Healthcare CEOs Unscripted: A View from the Top
NORTH CHICAGO, Ill. , Dec. 19, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 10th Annual Healthcare CEOs Unscripted: A View from the Top on Thursday, January 4, 2018 . Richard A. Gonzalez, chairman and chief executive officer, will present at 10 a.m. Central time .